Found Review

Our assessment

Found prices each compounded GLP-1 all-in, with care, medication and membership in one figure that holds as the dose rises. Tirzepatide costs more than semaglutide at every plan length. Every plan price is a 28-day cycle labeled as a month, and the lowest ones need a twelve-month plan the seller describes two different ways. The compounding pharmacy is never named, and Found's own pages disagree about where brand-name pricing starts.

Both roads, in one place

Found sells compounded semaglutide and tirzepatide, each prepared with B12 and glycine, on all-in plans. On a separate track it prescribes Wegovy, the Wegovy pill and Zepbound, which you buy at the manufacturer's price while Found charges its own membership. If you are still deciding between the two, that is the difference between one intake and two.

A compounded preparation is prepared by a compounding pharmacy and has not been through the FDA approval process a brand-name GLP-1 has. They are different purchases, and Found bills them differently: one plan price, or a membership plus a pharmacy bill. Found lets you weigh that trade-off without switching providers halfway through.

It is also why you shouldn't compare Found's compounded figure against another provider's compounded figure and stop there. The brand-name route sits behind the same account, and for some buyers that is the whole value of the platform.

Ozempic and Mounjaro have their own pages on the site, but neither carries a Found price.

One price per drug, not one price for both

Each compounded drug has its own price, and that price does not move as the dose climbs. Found says so on both compounded product pages. Start low, move up, and the bill stays where it was.

The two drugs do not share a price. Tirzepatide costs more than semaglutide at every plan length, with or without insurance, and the gap is close to the same on every cash plan. Switching from semaglutide to tirzepatide later means a higher bill from that cycle on.

Found also takes insurance for the clinical visits. Members whose plan is in network pay a lower plan price plus a visit copay. That is a real saving for some readers, and it is not the cash price.

A month here is 28 days

Found prints its plan prices per month. Its offer terms say every plan is billed every four weeks, and its own tables count a twelve-month term as forty-eight weeks.

Four-week billing means thirteen charges in a year, not twelve. A Found figure set beside another seller's monthly price is not the same unit, so allow for the extra charge before comparing.

The twelve-month plan behind the headline

Found's lowest advertised prices are its twelve-month plans. Paying month to month lands substantially higher on either drug. That is a large step, not a rounding difference, so a Found figure quoted without its plan term describes a purchase most people will not make.

The seller does not settle what the twelve-month plan charges. Its pricing page says those prices are based on plans paid up front. Its offer terms say every plan is billed every four weeks. No total for the year is printed anywhere.

A year's commitment is a real decision. It is a bet that treatment will suit you, that you will tolerate it and that you will want to continue. Anyone less certain should price Found at its month-to-month rate and see whether it still wins.

Found does publish a specific refund policy for its membership fee. It pays the fee back in full if you cancel within three days of purchase or before your first consultation, or if a consultation rules out every treatment. Read it against the plan term before deciding, because those two terms interact.

Where Found's own pages disagree

Found's pages are not consistent with each other on brand-name medication. The Wegovy store page gives one starting figure for the pen. Another Wegovy page on the same site quotes the manufacturer's own pharmacy at more than twice that for a 28-day supply.

Zepbound has the same problem. The store page and the Zepbound vials page give different figures for the lowest dose. A comparison table on the compounded pages adds a third set of figures, a range for each brand-name drug.

Nothing on the site reconciles them. Treat a brand-name price as something to confirm directly with Found for your own situation, not something to carry away from a page.

The compounded side is priced consistently across the offer terms and the product pages. The one thing it leaves open is how the twelve-month plan is billed.

What Found shows and what it withholds

Found displays a LegitScript seal in its site footer. A seal on a page establishes that a seal is published; it does not establish who holds the underlying certificate. If that credential is decisive for you, verify it at its source.

On the pharmacy question, Found goes no further than a licensing class: 503A. Which of those pharmacies fills a given order is never stated. A licensing category tells you what kind of pharmacy is involved without letting you look up the specific one.

It is more open about who treats you. Its product pages name four clinicians, and its terms name the medical groups it contracts with.

Where it operates

Found says it is available in every state except Alaska, Arkansas, Delaware, Louisiana, Mississippi, Rhode Island, Vermont, West Virginia and the District of Columbia.

Compounded medication reaches fewer places. Found never ships it to Alabama or Virginia. Compounded semaglutide also skips Indiana, Minnesota and South Carolina, and compounded tirzepatide skips those three and California.